Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | PLX-4720 | 1 | uM | 3 | 312.50 | 136.54 | 324.00 | 285.25 | 1.1358 | 1.2546 |
| BT-20 | NVP-TAE684 | 0.1 | uM | 3 | 312.50 | 136.54 | 394.00 | 285.25 | 1.3812 | 1.7102 |
| BT-20 | Nilotinib | 10 | uM | 3 | 312.50 | 136.54 | 610.00 | 285.25 | 2.1385 | 3.0889 |
| BT-20 | Nilotinib | 0.01 | uM | 3 | 312.50 | 136.54 | 389.00 | 285.25 | 1.3637 | 1.6778 |
| BT-20 | Etoposide | 19.9526 | uM | 3 | 312.50 | 136.54 | 167.00 | 285.25 | 0.5855 | 0.2086 |
| BT-20 | 0 | uM | 3 | 312.50 | 136.54 | 276.00 | 285.25 | 0.9676 | 0.9389 | |
| BT-20 | 0 | uM | 3 | 312.50 | 136.54 | 181.00 | 285.25 | 0.6345 | 0.3037 | |
| BT-20 | 0 | uM | 3 | 312.50 | 136.54 | 147.00 | 285.25 | 0.5153 | 0.0719 | |
| BT-20 | 0 | uM | 3 | 312.50 | 136.54 | 244.00 | 285.25 | 0.8554 | 0.7267 | |
| BT-20 | Etoposide | 1 | uM | 3 | 312.50 | 136.54 | 229.00 | 285.25 | 0.8028 | 0.6266 |
| BT-20 | NVP-TAE684 | 0.0016596 | uM | 3 | 312.50 | 136.54 | 267.00 | 285.25 | 0.9360 | 0.8794 |
| BT-20 | 0 | uM | 3 | 312.50 | 136.54 | 300.00 | 285.25 | 1.0517 | 1.0972 | |
| BT-20 | NVP-TAE684 | 10 | uM | 3 | 312.50 | 136.54 | 136.00 | 285.25 | 0.4768 | -0.0037 |
| BT-20 | Nilotinib | 0.0033113 | uM | 3 | 312.50 | 136.54 | 420.00 | 285.25 | 1.4724 | 1.8781 |
| BT-20 | NVP-TAE684 | 0.0033113 | uM | 3 | 312.50 | 136.54 | 315.00 | 285.25 | 1.1043 | 1.1957 |
| BT-20 | Nilotinib | 0.31623 | uM | 3 | 312.50 | 136.54 | 455.00 | 285.25 | 1.5951 | 2.1033 |
| BT-20 | PLX-4720 | 3.1623 | uM | 3 | 312.50 | 136.54 | 358.00 | 285.25 | 1.2550 | 1.4766 |
| BT-20 | NVP-TAE684 | 1 | uM | 3 | 312.50 | 136.54 | 262.00 | 285.25 | 0.9185 | 0.8463 |
| BT-20 | Etoposide | 0.1 | uM | 3 | 312.50 | 136.54 | 502.00 | 285.25 | 1.7599 | 2.4040 |
| BT-20 | Nilotinib | 0.031623 | uM | 3 | 312.50 | 136.54 | 416.00 | 285.25 | 1.4584 | 1.8523 |
| BT-20 | 0 | uM | 3 | 312.50 | 136.54 | 373.00 | 285.25 | 1.3076 | 1.5741 | |
| BT-20 | PLX-4720 | 19.9526 | uM | 3 | 312.50 | 136.54 | 214.00 | 285.25 | 0.7502 | 0.5262 |
| BT-20 | NVP-TAE684 | 0.31623 | uM | 3 | 312.50 | 136.54 | 367.00 | 285.25 | 1.2866 | 1.5351 |
| BT-20 | Nilotinib | 1 | uM | 3 | 312.50 | 136.54 | 379.00 | 285.25 | 1.3287 | 1.6130 |
| BT-20 | PLX-4720 | 0.31623 | uM | 3 | 312.50 | 136.54 | 352.00 | 285.25 | 1.2340 | 1.4375 |